Andrew G. Stead

2.5k total citations · 1 hit paper
54 papers, 2.0k citations indexed

About

Andrew G. Stead is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Andrew G. Stead has authored 54 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 14 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Andrew G. Stead's work include HER2/EGFR in Cancer Research (12 papers), Colorectal Cancer Treatments and Studies (10 papers) and Lung Cancer Treatments and Mutations (9 papers). Andrew G. Stead is often cited by papers focused on HER2/EGFR in Cancer Research (12 papers), Colorectal Cancer Treatments and Studies (10 papers) and Lung Cancer Treatments and Mutations (9 papers). Andrew G. Stead collaborates with scholars based in United States, United Kingdom and Austria. Andrew G. Stead's co-authors include Kevin M. Koch, Deborah A. Smith, Neil L. Spector, Afshin Dowlati, Howard A. Burris, Herbert I. Hurwitz, Beth Overmoyer, Bert H. O’Neil, Matthew J. Ellis and Kimberly Blackwell and has published in prestigious journals such as Journal of Clinical Oncology, Journal of the American Statistical Association and Stroke.

In The Last Decade

Andrew G. Stead

53 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phase I Safety, Pharmacokinetics, and Clinical Activity Study of Lapatinib (GW572016), a Reversible Dual Inhibitor of Epidermal Growth Factor Receptor Tyrosine Kinases, in Heavily Pretreated Patients With Metastatic Carcinomas

2005 503 citations Howard A. Burris, Herbert I. Hurwitz et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrew G. Stead United States	21	954	501	414	354	275	54	2.0k
Linda L. Garland United States	25	908 1.0×	1.0k 2.0×	539 1.3×	164 0.5×	182 0.7×	71	2.2k
Yukihiro Kondo Japan	25	404 0.4×	417 0.8×	718 1.7×	607 1.7×	103 0.4×	157	2.3k
Sandra Cerda United States	30	716 0.8×	468 0.9×	649 1.6×	236 0.7×	125 0.5×	72	2.2k
Kazuto Ito Japan	32	466 0.5×	1.7k 3.4×	730 1.8×	323 0.9×	210 0.8×	160	3.0k
Khalid Amin United States	21	419 0.4×	243 0.5×	767 1.9×	345 1.0×	209 0.8×	115	2.2k
Hung‐Ming Lam United States	24	770 0.8×	766 1.5×	1.1k 2.6×	494 1.4×	90 0.3×	57	2.5k
Linda Grass Canada	31	594 0.6×	355 0.7×	767 1.9×	325 0.9×	78 0.3×	43	2.6k
Juan Li China	22	411 0.4×	233 0.5×	964 2.3×	507 1.4×	72 0.3×	161	2.0k
Hirdesh Uppal United States	19	1.0k 1.1×	321 0.6×	572 1.4×	373 1.1×	154 0.6×	33	2.0k

Countries citing papers authored by Andrew G. Stead

Since Specialization

Citations

This map shows the geographic impact of Andrew G. Stead's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew G. Stead with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew G. Stead more than expected).

Fields of papers citing papers by Andrew G. Stead

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew G. Stead. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew G. Stead. The network helps show where Andrew G. Stead may publish in the future.

Co-authorship network of co-authors of Andrew G. Stead

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew G. Stead. A scholar is included among the top collaborators of Andrew G. Stead based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew G. Stead. Andrew G. Stead is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Burris, Howard A., Herbert I. Hurwitz, Elizabeth Claire Dees, et al.. (2005). Phase I Safety, Pharmacokinetics, and Clinical Activity Study of Lapatinib (GW572016), a Reversible Dual Inhibitor of Epidermal Growth Factor Receptor Tyrosine Kinases, in Heavily Pretreated Patients With Metastatic Carcinomas. Journal of Clinical Oncology. 23(23). 5305–5313. 503 indexed citations breakdown →

Spector, Neil L., Wenle Xia, Howard A. Burris, et al.. (2005). Study of the Biologic Effects of Lapatinib, a Reversible Inhibitor of ErbB1 and ErbB2 Tyrosine Kinases, on Tumor Growth and Survival Pathways in Patients With Advanced Malignancies. Journal of Clinical Oncology. 23(11). 2502–2512. 290 indexed citations

Bence, Aimee K., Michael Doukas, George A. Davis, et al.. (2004). Phase I pharmacokinetic studies evaluating single and multiple doses of oral GW572016, a dual EGFR-ErbB2 inhibitor, in healthy subjects. Investigational New Drugs. 23(1). 39–49. 98 indexed citations

Smith, Deborah A., et al.. (2004). An open-label, fixed sequence, two period study to evaluate the potential induction of GW572016 metabolism by carbamazepine. Journal of Clinical Oncology. 22(14_suppl). 3081–3081. 4 indexed citations

Dees, E. Claire, et al.. (2004). Clinical summary of 67 heavily pre-treated patients with metastatic carcinomas treated with GW572016 in a phase Ib study. Journal of Clinical Oncology. 22(14_suppl). 3188–3188. 13 indexed citations

Smith, Deborah A., et al.. (2004). An open-label, randomized, two-way crossover study to evaluate the potential inhibition of GW572016 metabolism by ketoconazole. Journal of Clinical Oncology. 22(14_suppl). 3071–3071. 3 indexed citations

Dees, E. Claire, H. Hurwitz, Afshin Dowlati, et al.. (2004). Clinical summary of 67 heavily pre-treated patients with metastatic carcinomas treated with GW572016 in a phase Ib study. Journal of Clinical Oncology. 22(14_suppl). 3188–3188. 4 indexed citations

Koch, Kevin M., Brian Corrigan, Claire D. James, et al.. (2004). Alosetron repeat dose pharmacokinetics, effects on enzyme activities, and influence of demographic factors. Alimentary Pharmacology & Therapeutics. 20(2). 223–230. 22 indexed citations

Ng, Valerie L., et al.. (1998). Highly Sensitive Thromboplastins Do Not Improve INR Precision. American Journal of Clinical Pathology. 109(3). 338–346. 7 indexed citations

10.

Jürgens, Günther, Wendy C. Taddei‐Peters, P Költringer, et al.. (1995). Lipoprotein(a) Serum Concentration and Apolipoprotein(a) Phenotype Correlate With Severity and Presence of Ischemic Cerebrovascular Disease. Stroke. 26(10). 1841–1848. 101 indexed citations

11.

Andrews, James E., et al.. (1990). Morphometric analysis of osteosclerotic bone resulting from hexachlorobenzene exposure. Journal of Toxicology and Environmental Health. 31(3). 193–201. 17 indexed citations

12.

Selgrade, MaryJane K., Gary E. Hatch, Elaine C. Grose, et al.. (1990). Pulmonary Effects due to Subchronic Exposure to Oil Fog. Toxicology and Industrial Health. 6(1). 123–143. 5 indexed citations

13.

Gordon, Christopher, et al.. (1989). Temperature regulation following nickel intoxication in the mouse: Effect of ambient temperature. Comparative Biochemistry and Physiology Part C Comparative Pharmacology. 92(1). 73–76. 5 indexed citations

14.

Gordon, Christopher J., et al.. (1988). BEHAVIORAL THERMOREGULATION IN THE RAT FOLLOWING THE ORAL ADMINISTRATION OF ETHANOL. Alcohol and Alcoholism. 23(5). 383–390. 19 indexed citations

15.

Gordon, Christopher J. & Andrew G. Stead. (1988). Effect of ethyl alcohol on thermoregulation in mice following the induction of hypothermia or hyperthermia. Pharmacology Biochemistry and Behavior. 29(4). 693–698. 9 indexed citations

16.

Claxton, Larry D., Andrew G. Stead, & Debra Walsh. (1988). An analysis by chemical class of Salmonella mutagenicity tests as predictors of animal carcinogenicity. Mutation Research/Genetic Toxicology. 205(1-4). 197–225. 40 indexed citations

17.

Allen, James W., Gary D. Stoner, Michael A. Pereira, et al.. (1986). Tumorigenesis and genotoxicity of ethyl carbamate and vinyl carbamate in rodent cells.. PubMed. 46(10). 4911–5. 23 indexed citations

18.

Mole, M.Leonard, Andrew G. Stead, Donald E. Gardner, Frederick J. Miller, & Judith A. Graham. (1985). Effect of ozone on serum lipids and lipoproteins in the rat. Toxicology and Applied Pharmacology. 80(3). 367–376. 6 indexed citations

19.

Stead, Andrew G., et al.. (1984). Automative quantification of rat duodenal rhythmic contraction. Bulletin of Environmental Contamination and Toxicology. 33(1). 169–176.

20.

Stead, Andrew G., et al.. (1977). Congenital hindlimb rigidity in a dog. Journal of Small Animal Practice. 18(1). 39–46. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact